Similar articles

• Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.

  Zhou HH, Tang Y, Zhang XY, Luo CX, Gao LY, Wu HY, Chang L, Zhu DY. Zhou HH, et al. Stroke. 2015 May;46(5):1352-8. doi: 10.1161/STROKEAHA.115.008886. Epub 2015 Apr 7. Stroke. 2015. Retraction in: Stroke. 2020 Apr;51(4):e72. doi: 10.1161/STR.0000000000000224. PMID: 25851770 Retracted.
• Response to Letter Regarding Article, "Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats".

  Zhou HH, Zhu DY. Zhou HH, et al. Stroke. 2015 Aug;46(8):e193. doi: 10.1161/STROKEAHA.115.010073. Epub 2015 Jun 25. Stroke. 2015. PMID: 26111894 No abstract available.
• Letter by Zuo and Xu Regarding Article, "Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats".

  Zuo X, Xu E. Zuo X, et al. Stroke. 2015 Aug;46(8):e192. doi: 10.1161/STROKEAHA.115.010019. Epub 2015 Jun 25. Stroke. 2015. PMID: 26111889 No abstract available.
• Cloning, expression, and purification of a recombinant Tat-HA-NR2B9c peptide.

  Zhou HH, Zhang AX, Zhang Y, Zhu DY. Zhou HH, et al. Protein Expr Purif. 2012 Oct;85(2):239-45. doi: 10.1016/j.pep.2012.08.011. Epub 2012 Aug 25. Protein Expr Purif. 2012. PMID: 22944204
• Tat-HA-NR2B9c attenuate oxaliplatin-induced neuropathic pain.

  Zhou HH, Zhang L, Zhang HX, Xu BR, Zhang JP, Zhou YJ, Qian XP, Ge WH. Zhou HH, et al. Exp Neurol. 2019 Jan;311:80-87. doi: 10.1016/j.expneurol.2018.09.014. Epub 2018 Sep 22. Exp Neurol. 2019. PMID: 30253135